0001404644-24-000067.txt : 20240617 0001404644-24-000067.hdr.sgml : 20240617 20240617143537 ACCESSION NUMBER: 0001404644-24-000067 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240614 FILED AS OF DATE: 20240617 DATE AS OF CHANGE: 20240617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Freedland Cory S. CENTRAL INDEX KEY: 0001832569 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36327 FILM NUMBER: 241047790 MAIL ADDRESS: STREET 1: 628 MIDDLEFIELD ROAD CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Neurogene Inc. CENTRAL INDEX KEY: 0001404644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 980542593 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 W 24TH STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: (877) 237-5020 MAIL ADDRESS: STREET 1: 535 W 24TH STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 FORMER COMPANY: FORMER CONFORMED NAME: Neoleukin Therapeutics, Inc. DATE OF NAME CHANGE: 20190812 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC DATE OF NAME CHANGE: 20140128 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC DATE OF NAME CHANGE: 20070626 4 1 wk-form4_1718649330.xml FORM 4 X0508 4 2024-06-14 0 0001404644 Neurogene Inc. NGNE 0001832569 Freedland Cory S. C/O NEUROGENE INC. 535 W 24TH STREET, 5TH FLOOR NEW YORK NY 10011 1 0 0 0 0 Stock Option (Right to Buy) 42.59 2024-06-14 4 A 0 7700 0 A 2034-06-14 Common Stock 7700 7700 D This option represents a right to purchase 7,700 shares of the Issuer's common stock, which will vest in its entirety on the earlier of (a) the first anniversary of the date of grant or (b) the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such applicable vesting date. /s/ Christine Mikail, as attorney-in-fact for Cory S. Freedland 2024-06-17